94 results
Page 3 of 5
424B5
85sw axvhp37y80
1 Sep 23
Prospectus supplement for primary offering
4:30pm
S-3
sm1bwq0twczp5wj2hap6
14 Aug 23
Shelf registration
6:05pm
8-K
wmg8kxht
8 Aug 23
MAIA Biotechnology Reports Second Quarter 2023 Financial Results and Provides Updates for THIO-101 Phase 2 Trial for Non-Small Cell Lung Cancer
8:15am
8-K
EX-99.1
5yxrwu 6i3v4
8 Aug 23
MAIA Biotechnology Reports Second Quarter 2023 Financial Results and Provides Updates for THIO-101 Phase 2 Trial for Non-Small Cell Lung Cancer
8:15am
8-K
EX-99.1
7wvpoj
11 Jul 23
MAIA Biotechnology Reports Updates on Disease Control Rates for THIO-101 Phase 2 Trial for Advanced Non-Small Cell Lung Cancer
10:26am
8-K
EX-99.1
bzwuhs qhthwog9mp
10 Jul 23
MAIA Biotechnology Reports Updates on Preliminary Survival Data for THIO-101 Phase 2 Trial for Advanced Non-Small Cell Lung Cancer
4:41pm
8-K
EX-99.1
96b6trg
20 Jun 23
Regulation FD Disclosure
9:06am
DRS
l51t6o4i5 smb6xz
1 Jun 23
Draft registration statement
12:00am
8-K
EX-99.1
kt9vpu21 agd113xyt
8 May 23
MAIA Biotechnology Reports First Quarter 2023 Financial Results and Provides Corporate Update
8:15am
8-K
emxc4 icwanpw8
8 May 23
MAIA Biotechnology Reports First Quarter 2023 Financial Results and Provides Corporate Update
8:15am
8-K
qyrgpb
27 Apr 23
MAIA Biotechnology, Inc. Announces Pricing of Public Offering
5:25pm
8-K
EX-99.1
ayw sk2dnuzyaugi
27 Apr 23
MAIA Biotechnology, Inc. Announces Pricing of Public Offering
5:25pm
8-K
EX-99.2
76ez sfva
27 Apr 23
MAIA Biotechnology, Inc. Announces Pricing of Public Offering
5:25pm
424B4
pvg bjhnduupgo7g2h2w
25 Apr 23
Prospectus supplement with pricing info
7:45pm
8-K
EX-99.1
s2ihsmwryjqvr 0wo9
20 Apr 23
MAIA Biotechnology Reports Preliminary Survival Data in Part A of THIO-101 Phase 2 Trial for Non-Small Cell Lung Cancer
8:43am